Prognostic factors study of differentiated thyroid cancer Estudio de los factores pronosticadores de la sobrevida del cáncer diferenciado del tiroides
Author
dc.contributor.author
Domínguez E., Miguel
Author
dc.contributor.author
Torres O., José
Author
dc.contributor.author
Pérez P., Gilberto
Author
dc.contributor.author
Volpato V., Roberto
Author
dc.contributor.author
Jadresic V, Alfredo
Author
dc.contributor.author
López C., Enrique
Admission date
dc.date.accessioned
2019-03-11T13:02:58Z
Available date
dc.date.available
2019-03-11T13:02:58Z
Publication date
dc.date.issued
2011
Cita de ítem
dc.identifier.citation
Revista Chilena de Cirugia, Volumen 63, Issue 6, 2018, Pages 566-572
Identifier
dc.identifier.issn
07184026
Identifier
dc.identifier.issn
03793893
Identifier
dc.identifier.uri
https://repositorio.uchile.cl/handle/2250/165417
Abstract
dc.description.abstract
The aim of this investigation was to evaluate the prognostic factors in patients with differentiated thyroid carcinoma treated and followed for a long period of time. Patients and Method: The following prognostic variables: gender, age at diagnosis, goiter characteristics, histology, differentiation grades, tumor anatomical extension, lymph node and distant initial metastasis and post treatment evolution were studied in a historical cohort of thyroid carcinoma. Surgical treatment was subtotal and total thyroidectomy plus lymphatic cervical selective neck dissection. Radioiodine was employed en 59.2% and thyroid hormone replacement was used indefinitely. Kaplan Meyer analisis was employed to plot survival curves, log Rank test was used to establish the significance of each variable and square chi to determine differences among groups. Cox model was used to identify prognostic variables. Results: A group of 477 patients with differentiated thyroid carcinoma treated at the Hospital San Ju